PLASMACYTOMA

Clinical trials for PLASMACYTOMA explained in plain language.

Never miss a new study

Get alerted when new PLASMACYTOMA trials appear

Sign up with your email to follow new studies for PLASMACYTOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 1 Terminated 1

New combo therapy for tough myeloma cases shows promise in early trial

Disease control Terminated

This early-phase study tested a new drug (KRT-232) combined with three standard myeloma treatments in 35 patients whose cancer had come back or stopped responding. The goal was to find the safest dose and check for side effects. The study was stopped early, but the information ga…

Matched conditions: PLASMACYTOMA

Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated May 06, 2026 16:02 UTC

PLASMACYTOMA

Get alerted when new PLASMACYTOMA trials appear

New combo therapy for tough myeloma cases shows promise in early trial